[心包炎：2025年的现状与展望]。

Q4 Medicine

Revue medicale suisse Pub Date : 2025-03-05 DOI:10.53738/REVMED.2025.21.908.449

Sélim Forster, Alain Delabays, Oscar Marchetti, Vladimir Rubimbura

{"title":"[心包炎：2025年的现状与展望]。","authors":"Sélim Forster, Alain Delabays, Oscar Marchetti, Vladimir Rubimbura","doi":"10.53738/REVMED.2025.21.908.449","DOIUrl":null,"url":null,"abstract":"Since 2015, the European Society of Cardiology's recommendations on the management of pericarditis have adapted to immunological advances. The main etiologies are viral. Diagnosis is based on clinical criteria, biological markers, ECG and cardiac imaging. Treatment combines non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with alternative options for recurrent and refractory forms such as corticosteroids, rilonacept and anakinra. The management strategy is adjusted according to patient characteristics and imaging: MRI plays a crucial role in assessing inflammation and monitoring treatment efficacy.","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 908","pages":"449-453"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Pericarditis: state-of-the art and perspectives in 2025].\",\"authors\":\"Sélim Forster, Alain Delabays, Oscar Marchetti, Vladimir Rubimbura\",\"doi\":\"10.53738/REVMED.2025.21.908.449\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since 2015, the European Society of Cardiology's recommendations on the management of pericarditis have adapted to immunological advances. The main etiologies are viral. Diagnosis is based on clinical criteria, biological markers, ECG and cardiac imaging. Treatment combines non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with alternative options for recurrent and refractory forms such as corticosteroids, rilonacept and anakinra. The management strategy is adjusted according to patient characteristics and imaging: MRI plays a crucial role in assessing inflammation and monitoring treatment efficacy.\",\"PeriodicalId\":21286,\"journal\":{\"name\":\"Revue medicale suisse\",\"volume\":\"21 908\",\"pages\":\"449-453\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue medicale suisse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53738/REVMED.2025.21.908.449\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.908.449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

自2015年以来，欧洲心脏病学会关于心包炎管理的建议已经适应了免疫学的进步。主要病因是病毒。诊断是基于临床标准，生物标志物，心电图和心脏成像。治疗方法包括非甾体抗炎药（NSAIDs）和秋水仙碱，以及复发性和难治性形式的替代选择，如皮质类固醇、rilonaccepept和anakinra。根据患者特点和影像学调整治疗策略：MRI在评估炎症和监测治疗效果方面起着至关重要的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Pericarditis: state-of-the art and perspectives in 2025].

Since 2015, the European Society of Cardiology's recommendations on the management of pericarditis have adapted to immunological advances. The main etiologies are viral. Diagnosis is based on clinical criteria, biological markers, ECG and cardiac imaging. Treatment combines non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with alternative options for recurrent and refractory forms such as corticosteroids, rilonacept and anakinra. The management strategy is adjusted according to patient characteristics and imaging: MRI plays a crucial role in assessing inflammation and monitoring treatment efficacy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revue medicale suisse Medicine-Medicine (all)

CiteScore

0.60

自引率

0.00%

发文量

1210

期刊介绍： Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.